Forest Hills Lab Announces Results From Phase 1 Trial Of FHL-101 Glyceryl Tribenzoate For Neurological Conditions
(MENAFN - EIN Presswire) HONG KONG, SAR, January 31, 2024 /EINPresswire / -- Forest Hills Lab (–FHL–), an innovative global life sciences company focused on regenerative medicine and medical ... ...
Source: wn.com